Index | ARK Genomic Revolution |
Investment focus | Equity, World, Health Care |
Fund size | GBP 2 m |
Total expense ratio | 0.75% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Actively managed |
Sustainability | Yes |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | - |
Inception/ Listing Date | 12 April 2024 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | ARK Invest International |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | Northern Trust International Fund Administration Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | Northern Trust Fiduciary Services (Ireland) Limited |
Revision Company | Deloitte Ireland LLP |
Fiscal Year End | 1 June |
Swiss representative | - |
Swiss paying agent | - |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | - |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
Twist Bioscience | 7.95% |
CRISPR Therapeutics | 6.92% |
CareDx | 6.57% |
Recursion Pharmaceuticals | 5.76% |
Arcturus Therapeutics Holdings, Inc. | 4.54% |
Moderna, Inc. | 4.03% |
Intellia Therapeutics | 3.94% |
Schrodinger | 3.87% |
Ionis Pharmaceuticals | 3.65% |
Beam Therapeutics, Inc. | 3.61% |
United States | 89.97% |
Switzerland | 6.92% |
United Kingdom | 1.11% |
Other | 2.00% |
Health Care | 93.27% |
Technology | 2.95% |
Basic Materials | 2.40% |
Other | 1.38% |
YTD | - |
1 month | -0.54% |
3 months | -1.62% |
6 months | - |
1 year | - |
3 years | - |
5 years | - |
Since inception (MAX) | -5.44% |
2023 | - |
2022 | - |
2021 | - |
2020 | - |
Volatility 1 year | - |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | - |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | - |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -15.37% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
Borsa Italiana | EUR | ARKG | - - | - - | - |
XETRA | EUR | AAKG | - - | - - | - |
gettex | EUR | AAKG | - - | - - | - |
London Stock Exchange | GBX | ARCG | |||
London Stock Exchange | USD | ARKG |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 1,022 | 0.40% p.a. | Accumulating | Sampling |
L&G Healthcare Breakthrough UCITS ETF USD Acc | 65 | 0.49% p.a. | Accumulating | Full replication |
L&G Pharma Breakthrough UCITS ETF | 17 | 0.49% p.a. | Accumulating | Full replication |
HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF | 15 | 0.59% p.a. | Accumulating | Full replication |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 7 | 0.35% p.a. | Accumulating | Full replication |